The end of 'Chevron deference' doctrine could have ripple effects across the entire nicotine industry in the United States.Read More
Tags :PMTA
The FDA has okayed far more combustibles than vapes since the 2020 filing deadline.Read More
The FDA is contesting a lower court ruling favoring two vaping firms' PMTA submissions.Read More
What we can learn from the first FDA marketing order for menthol ENDS, according to Broughton CEO Chris Allen.Read More
The FDA’s first premarket approval of a mentholated vape product reflects poorly on the agency’s authorization process.Read More
The device verifies users’ ages through a third-party vendor.Read More
On! Plus is seamless and larger than leading U.S. tobacco-derived nicotine brands. Read More
Activists call for stronger enforcement.Read More
Only a handful of lower-risk products have been authorized for sale in the U.S. Read More
The U.S. Food and Drug Administration is seeking about $20,000 from each.Read More
